Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC trimmed its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 0.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,607,595 shares of the company’s stock after selling 9,800 shares during the period. Ryan Specialty makes up about 1.4% of Stephens Investment Management Group LLC’s holdings, making the stock its 9th largest holding. Stephens Investment Management Group LLC’s holdings in Ryan Specialty were worth $103,143,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Hollencrest Capital Management purchased a new position in shares of Ryan Specialty during the 3rd quarter worth $25,000. Assetmark Inc. purchased a new position in Ryan Specialty during the third quarter worth about $34,000. Quarry LP increased its position in shares of Ryan Specialty by 109.3% during the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after acquiring an additional 422 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Ryan Specialty by 106.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock valued at $83,000 after acquiring an additional 644 shares during the period. Finally, Signaturefd LLC boosted its position in shares of Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after purchasing an additional 148 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Stock Down 0.4 %

Shares of NYSE:RYAN opened at $68.24 on Friday. Ryan Specialty Holdings, Inc. has a twelve month low of $42.68 and a twelve month high of $75.97. The company has a market capitalization of $17.87 billion, a PE ratio of 88.63, a P/E/G ratio of 1.19 and a beta of 0.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a 50 day simple moving average of $66.12 and a 200-day simple moving average of $66.87.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 31,409 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the sale, the director now owns 2,697 shares in the company, valued at approximately $177,031.08. This represents a 92.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 323,506 shares of company stock valued at $21,407,851. Insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

RYAN has been the subject of a number of research reports. Wells Fargo & Company dropped their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Morgan Stanley assumed coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price on the stock. Keefe, Bruyette & Woods cut their price objective on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research report on Friday, January 10th. Finally, Barclays boosted their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $74.40.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.